Illumina Inc. Stock
Illumina Inc. Stock
Heavy losses for Illumina Inc. today as the stock fell by -€13.600 (-4.040%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Illumina Inc. stock is not clear.
Our community identified positive and negative aspects for Illumina Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Illumina Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Illumina Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Illumina Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Illumina Inc. | -4.040% | -9.042% | -3.985% | -2.989% | -3.207% | 17.538% | 116.406% |
| Intuitive Surgical Inc | -7.760% | -11.837% | -23.032% | 8.559% | -26.027% | 48.065% | 246.300% |
| PerkinElmer Inc. | -0.580% | -1.312% | -7.995% | 24.355% | -11.532% | 106.952% | 234.099% |
| Boston Scientific | -1.460% | -3.562% | 4.007% | 22.912% | -0.551% | 13.916% | 67.788% |
Comments
Other discussions about Illumina Inc. Stock
Trading Illumina Inc.
Trading Illumina Inc.
News
Illumina to Webcast Upcoming Investor Conference
Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
-
UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021
